• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AbbVie (NY:ABBV)

227.50 +6.61 (+2.99%)
Official Closing Price Updated: 7:00 PM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,711,959
Open 221.57
Bid (Size) 227.00 (100)
Ask (Size) 228.00 (1,200)
Prev. Close 220.89
Today's Range 220.91 - 229.05
52wk Range 164.39 - 244.81
Shares Outstanding N/A
Dividend Yield 3.04%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The Great Rotation: Healthcare Emerges as the S&P 500’s New Crown Jewel in 2026
Today 17:24 EST
As of February 12, 2026, the financial landscape has undergone a tectonic shift, with the healthcare sector decisively seizing the mantle of market leadership. After years of dominance by high-flying... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
1 Reason I'm Never Selling AbbVie Stock ↗
Today 5:04 EST
This Dividend King has staying power. 
Via The Motley Fool
Topics Intellectual Property

Performance

YTD
-0.8%
-0.8%
1 Month
+3.4%
+3.4%
3 Month
-2.5%
-2.5%
6 Month
+12.9%
+12.9%
1 Year
+18.6%
+18.6%

More News

Read More
News headline image
Incyte (INCY) Deep Dive: Navigating the 2026 Crossroads Following Earnings Miss
February 11, 2026
Via Finterra
Topics Economy Intellectual Property
AbbVie Inc. (NYSE:ABBV) Raises 2026 Outlook Despite Q4 Revenue Miss ↗
February 04, 2026
Via Chartmill
News headline image
The 5 Most Interesting Analyst Questions From AbbVie’s Q4 Earnings Call
February 11, 2026
Via StockStory
Topics Earnings
News headline image
Silver and Gold Prices Are Volatile. Buy This ETF for Safety This Year ↗
February 10, 2026
Via The Motley Fool
Topics ETFs
News headline image
Novel Serotonergic Agonists Positioned to Capture Share of $150B+ Neuropsychiatric Market
February 10, 2026
Via FinancialNewsMedia
News headline image
3 Market-Beating Stocks to Research Further
February 08, 2026
Via StockStory
News headline image
The Great Pipeline Grab: Life Sciences Deal Volume Skyrockets 82% as Big Pharma Battles the Patent Cliff
February 06, 2026
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
AbbVie’s Prognosis: The February Dip Looks Like a Buy Signal ↗
February 05, 2026
Via MarketBeat
News headline image
ABBV Q4 Deep Dive: Immunology and Neuroscience Growth Offset Aesthetics Softness and Pricing Headwinds
February 05, 2026
Via StockStory
News headline image
AbbVie (ABBV) Q4 2025 Earnings Call Transcript ↗
February 04, 2026
Via The Motley Fool
Topics Earnings
Gapping S&P500 stocks in Wednesday's session ↗
February 04, 2026
Via Chartmill
Stay updated with the S&P500 stocks that are on the move in today's pre-market session. ↗
February 04, 2026
Via Chartmill
News headline image
AbbVie’s (NYSE:ABBV) Q4 CY2025: Beats On Revenue
February 04, 2026
Via StockStory
News headline image
2 Healthcare Dividend Stocks That are Just What the Doctor Ordered ↗
February 03, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
AbbVie (ABBV) Q4 Earnings: What To Expect
February 02, 2026
Via StockStory
News headline image
The Sound of Silence: Revolution Medicines Plummets 17% as M&A Hopes Evaporate
February 02, 2026
Via MarketMinute
Topics ETFs Government Initial Public Offering
News headline image
Where Will AbbVie Be in 5 Years? ↗
February 02, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
2 No-Brainer Dividend Stocks to Buy Hand Over Fist ↗
February 01, 2026
Via The Motley Fool
Topics Economy Intellectual Property
News headline image
Better Long-Term Buy: This Emerging Player or the Industry Leader? ↗
January 30, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Q3 Earnings Highs And Lows: AbbVie (NYSE:ABBV) Vs The Rest Of The Therapeutics Stocks
January 28, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
Why AbbVie Stock Trounced the Market in 2025 ↗
January 28, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Eli Lilly Reinforces Immunology Dominance with $1.2 Billion Acquisition of Ventyx Biosciences
January 27, 2026
Via MarketMinute
News headline image
Why Revolution Medicines Stock Plummeted by Almost 17% Today ↗
January 26, 2026
Via The Motley Fool

Frequently Asked Questions

Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 227.50
When was AbbVie last traded?
The last trade of AbbVie was at 02/12/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap